The type II receptor complex activates OSM-specific signaling pathways via the JNK/SAPK and Stat1/Stat5 pathways, whereas both type I and type II complexes activate Stat3 and Erk as common signaling pathways in breast cancer cells [41]. This evidence concerns the gene MAPK9 and breast cancer.